Internal Medicine, Nephrology · Miami, FL
NPI
1922091248
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9193 Sunset Dr, Suite 200
Miami, FL, 33173
Phone (305) 273-9377
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
555 services
Medicare patients, 2024
207
Average age 77
Drug cost, 2024
$1.1M
3,798 prescriptions
Company payments, 2025
$2,364
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge C Busse was code 99214 (office e&m - established), 304 times for 164 patients. In total Jorge C Busse billed 555 services in 14 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 304 | 164 | $94.14 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 136 | 96 | $11.63 | $1,582 |
| 99204 Office E&M - New | Office | 38 | 38 | $122.71 | $4,663 |
By year: 2022 $184K for 1,610 services; 2023 $145K for 1,295 services; 2024 $49K for 555 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jorge C Busse prescribed most often to Medicare patients was Ezetimibe, with 494 prescriptions and refills. In total Jorge C Busse wrote 3,798 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 494 | 1,331 | 178 | $8,950 |
| Allopurinol Generic | 366 | 932 | 106 | $3,031 |
| Bumetanide Generic | 327 | 803 | 112 | $9,810 |
| Rosuvastatin Calcium Generic | 267 | 716 | 95 | $3,095 |
| Farxiga Dapagliflozin Propanediol | 218 | 453 | 65 | $250K |
| Atorvastatin Calcium Generic | 204 | 531 | 69 | $1,477 |
| Amlodipine Besylate Generic | 174 | 486 | 58 | $1,354 |
| Pentoxifylline Generic | 149 | 291 | 33 | $3,941 |
| Losartan Potassium Generic | 147 | 405 | 48 | $1,181 |
| Procrit Epoetin Alfa | 107 | 107 | 11 | $70K |
| Methenamine Hippurate Generic | 80 | 161 | 25 | $8,424 |
| Furosemide Generic | 78 | 200 | 21 | $437 |
| Veltassa Patiromer Calcium Sorbitex | 77 | 84 | 18 | $86K |
| Kerendia Finerenone | 70 | 116 | 14 | $75K |
| Retacrit Epoetin Alfa-Epbx | 68 | 68 | 17 | $18K |
Brand drugs: - claims; generic drugs: 2,920 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge C Busse $2,364 ($2,364 in general payments such as food, travel and fees) from 18 companies. The largest payer was Calliditas Therapeutics US Inc. with $326.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 12 | $326 |
| Travere Therapeutics, Inc. TVTX | 13 | $218 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $212 |
| Vifor Pharma, Inc. | 8 | $206 |
| Ardelyx, Inc. ARDX | 10 | $200 |
| Aurinia Pharma U.S., Inc. AUPH | 9 | $193 |
| Amgen Inc. AMGN | 11 | $182 |
| Mallinckrodt Hospital Products Inc. | 6 | $179 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $166 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.